文献速递细胞病理与分子病理神经与头颈病理

DICER1突变或PTEN改变甲状腺结节的细胞学、临床与分子比较研究

Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases.
PubMed 文献 · Cancer Cytopathol · 2024-04-01

该研究比较了117例DICER1突变或PTEN改变的甲状腺细针穿刺(FNA)病例。DICER1组36例(30.8%),PTEN组81例(69.2%)。

要点

  • DICER1突变与PTEN改变的甲状腺FNA细胞学特征重叠,尤其是微滤泡模式。
  • DICER1患者平均年龄40.9岁,PTEN患者55.2岁,提示年龄差异。

核心结论

  • DICER1与PTEN改变的甲状腺FNA细胞学表现有许多相似之处,但DICER1患者更年轻,PTEN患者多结节病变更多。
  • 认识这些遗传队列有助于识别甲状腺癌风险患者。

研究设计与样本

  • 回顾性比较研究,从两个学术医学机构数据库检索117例DICER1或PTEN改变的甲状腺FNA病例。
  • 收集人口学、临床和影像学数据,分析29项细胞形态学特征。

主要发现

  • 117例FNA中,36例(30.8%)有DICER1突变,81例(69.2%)有PTEN改变。
  • DICER1组:女性33例(91.7%),男性3例(8.3%),平均年龄40.9岁,61.8%有多结节病变。
  • DICER1组FNA分类:AUS 23例(63.9%),FN 12例(33.3%),恶性1例(2.8%)。
  • PTEN组FNA分类:非诊断性2例(2.5%),良性5例(6.2%),AUS 44例(54.3%),FN 24例(29.6%),恶性6例(7.4%)。

临床怎么用

  • 对于甲状腺FNA提示DICER1突变或PTEN改变的患者,应结合年龄、多结节病变等临床特征评估甲状腺癌风险。
  • 细胞学出现微滤泡模式时,需考虑DICER1或PTEN相关肿瘤可能,并建议分子检测辅助诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: DICER1 mutations and PTEN alterations are increasingly detected by thyroid fine-needle aspiration (FNA). Both are associated with nodular thyroid disease and cancer. The authors analyzed a large comparative thyroid FNA cohort with DICER1 mutation or PTEN alteration. METHODS: A total of 117 thyroid FNAs with DICER1 or PTEN alterations were retrieved from the databases of two academic medical institutions. Demographic, clinical, and radiologic data were collected; FNA slides were analyzed for 29 cytomorphologic features. RESULTS: Of 117 thyroid FNAs, 36 (30.8%) had DICER1 mutation and 81 (69.2%) showed PTEN alteration. The DICER1 cohort had 33 (91.7%) females and three (8.3%) males (mean, 40.9 years); 61.8% had multinodular disease. FNAs were classified as atypia of undetermined significance (AUS), 23 (63.9%); follicular neoplasm (FN), 12 (33.3%); and malignant, 1 (2.8%). The PTEN subgroup had 66 (81.5%) females and 15 (18.5%) males (mean, 55.2 years) with increased multinodular disease (93.8%, p = .0016). PTEN FNAs had greater cytologic diversity: non-diagnostic, 2 (2.5%); benign, 5 (6.2%); AUS, 44 (54.3%); FN, 24 (29.6%); and malignant, 6 (7.4%). Both DICER1 and PTEN cases showed a range of resected tumor subtypes. The DICER1 cohort included thyroblastoma, and the PTEN group included anaplastic carcinoma. The cytomorphology of DICER1 and PTEN cases showed overlapping features, especially microfollicular patterns. Minor cytomorphologic differences included papillary patterns in DICER1 (p = .039), and oncocytic changes (p < .0001) in PTEN. CONCLUSIONS: DICER1 and PTEN FNAs reveal many cytologic similarities. DICER1 patients are younger, and PTEN patients had multinodular disease. Awareness of these genetic cohorts can identify patients at risk for thyroid cancer.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Jitpasutham T, Andrianus S, Gubbiotti M, et al. Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases. Cancer Cytopathol. 2024. PMID: 38558329. doi:10.1002/cncy.22811

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。